Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences
Willemijn A. van Gastel, Annabel Vreeker, Chris D. Schubart, et al.
Schizophrenia Research (2014) Vol. 157, Iss. 1-3, pp. 266-270
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
Gabriella Gobbi, Tobias Atkin, Tomasz Zytynski, et al.
JAMA Psychiatry (2019) Vol. 76, Iss. 4, pp. 426-426
Open Access | Times Cited: 675
Cannabis consumption and psychosis or schizophrenia development
María Bettina Ortiz-Medina, Marta Perea-Ortueta, Júlio Torales, et al.
International Journal of Social Psychiatry (2018) Vol. 64, Iss. 7, pp. 690-704
Closed Access | Times Cited: 85
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 67
Focus on psychosis
Wolfgang Gäebel, Jürgen Zielasek
Dialogues in Clinical Neuroscience (2015) Vol. 17, Iss. 1, pp. 9-18
Open Access | Times Cited: 85
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
José Trigo, Dina Lagzdins, Jürgen Rehm, et al.
Drug and Alcohol Dependence (2016) Vol. 161, pp. 298-306
Open Access | Times Cited: 84
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Nir Treves, Noa Mor, Karel Allegaert, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Musa Sami, Sagnik Bhattacharyya
Journal of Psychopharmacology (2018) Vol. 32, Iss. 8, pp. 825-849
Open Access | Times Cited: 44
Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder
Petter Andreas Ringen, Ragnar Nesvåg, Siri Helle, et al.
Psychological Medicine (2016) Vol. 46, Iss. 15, pp. 3127-3136
Closed Access | Times Cited: 43
BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction
Hadar Segal‐Gavish, Neta Gazit, Yael Barhum, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 13, pp. 2462-2471
Open Access | Times Cited: 39
Cannabis use as a risk factor for psychotic‐like experiences: A systematic review of non‐clinical populations evaluated with the Community Assessment of Psychic Experiences
Taciana Cristina Carvalho Ragazzi, Rosana Shuhama, Paulo Rossi Menezes, et al.
Early Intervention in Psychiatry (2018) Vol. 12, Iss. 6, pp. 1013-1023
Closed Access | Times Cited: 33
Prenatal cannabis exposure and the risk for neuropsychiatric anomalies in the offspring: a systematic review and meta-analysis
Hely Bassalov, Noa Yakirevich-Amir, Inbal Reuveni, et al.
American Journal of Obstetrics and Gynecology (2024) Vol. 231, Iss. 6, pp. 574-588.e8
Closed Access | Times Cited: 3
Psychotic experiences and subjective cognitive complaints among 224 842 people in 48 low- and middle-income countries
Ai Koyanagi, Brendon Stubbs, Elvira Lara, et al.
Epidemiology and Psychiatric Sciences (2018) Vol. 29
Open Access | Times Cited: 28
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
Eline Borger Rognli, Jørgen G. Bramness, Svetlana Skurtveit, et al.
Journal of Substance Abuse Treatment (2016) Vol. 74, pp. 42-47
Closed Access | Times Cited: 22
Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis
Musa Sami, Caitlin Notley, Christos Kouimtsidis, et al.
Psychological Medicine (2018) Vol. 49, Iss. 1, pp. 103-112
Open Access | Times Cited: 21
A Web-Based Program for Cannabis Use and Psychotic Experiences in Young People (Keep It Real): Protocol for a Randomized Controlled Trial
Leanne Hides, Amanda Baker, Melissa M. Norberg, et al.
JMIR Research Protocols (2019) Vol. 9, Iss. 7, pp. e15803-e15803
Open Access | Times Cited: 18
Cannabis Use, Psychotic Like Experiences and Aberrant Salience in a Sample of Belgian Students
Francesco Bernardini, Chiara Gobbicchi, Luigi Attademo, et al.
The Journal of Nervous and Mental Disease (2018) Vol. 206, Iss. 7, pp. 493-500
Closed Access | Times Cited: 16
Limitations to the Dutch cannabis toleration policy
Margriet van Laar, Peggy van der Pol, Raymond J.M. Niesink
International Journal of Drug Policy (2016) Vol. 34, pp. 58-64
Closed Access | Times Cited: 13
Validation of the Portuguese version of the Community Assessment of Psychic Experiences and characterization of psychotic experiences in a Brazilian sample
Taciana Cristina Carvalho Ragazzi, Rosana Shuhama, Jorge Sinval, et al.
Brazilian Journal of Psychiatry (2020) Vol. 42, Iss. 4, pp. 389-397
Open Access | Times Cited: 13
Cannabis-Associated Psychotic-like Experiences Are Mediated by Developmental Changes in the Parahippocampal Gyrus
Tao Yu, Tianye Jia, Liping Zhu, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2019) Vol. 59, Iss. 5, pp. 642-649
Open Access | Times Cited: 11
Is there sufficient evidence that cannabis use is a risk factor for psychosis?
Marco Colizzi, Sagnik Bhattacharyya
Elsevier eBooks (2020), pp. 305-331
Closed Access | Times Cited: 8
The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder
Nanna Gilliam Toftdahl, Merete Nordentoft, Carsten Hjorthøj
Journal of Dual Diagnosis (2016) Vol. 12, Iss. 2, pp. 129-136
Closed Access | Times Cited: 5
Are psychotic-like experiences related to a discontinuation of cannabis consumption in young adults?
Laura S. Daedelow, Tobias Banaschewski, Moritz Berning, et al.
Schizophrenia Research (2021) Vol. 228, pp. 271-279
Open Access | Times Cited: 4
Characterization of Cannabis users and products and the experience of negative mental emotions following Cannabis use
Nir Treves, Noa Yakirevich-Amir, Wiessam Abu Ahmad, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access
Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: Preliminary results
Branka Aukst Margetić, Vjekoslav Peitl, Ines Vukasović, et al.
Schizophrenia Research (2019) Vol. 208, pp. 473-474
Closed Access | Times Cited: 2
Cannabis Use and First-Episode Psychosis Patients (FEP)
Itxaso González–Ortega, Mónica Martínez‐Cengotitabengoa, Ana González‐Pinto
Elsevier eBooks (2017), pp. 257-266
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top